Aeglea BioTherapeutics (AGLE) Q1 2023 Earnings

May 11Confirmed
Aug 2022
Nov 2022
Q4 2022
Q1 2023
-0.31
-0.27
-0.22
-0.18

Details

Expected EPS
-0.18
Actual EPS
-0.2
Surprise EPS
-0.02
Surprise Percent
-11.11%

Description

⁨Aeglea BioTherapeutics⁩ (⁦AGLE⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts